Stock Events

Stock Events

LakeShore Biopharma 

$0.63
7
-$0.16-20.68% Friday 20:00

Statistics

Day High
-
Day Low
-
52W High
5.47
52W Low
0.3
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31JulExpected
Q4 0
Q1 2024
Q2 2024
Q3 2024
Q2 2025
-0.94
-0.62
-0.3
0.02
Expected EPS
N/A
Actual EPS
-0.73

Financials

-75.59%Profit Margin
Unprofitable
2020
2021
2022
2023
79.17MRevenue
-59.85MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LSB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap10.61B
Moderna, Inc. competes in the biotechnology and pharmaceuticals space, focusing on mRNA-based therapies, similar to YS Biopharma's focus on innovative biopharmaceuticals.
BioNTech
BNTX
Mkt Cap24.99B
BioNTech SE operates in the field of mRNA technology for developing vaccines and therapeutics, directly competing with YS Biopharma's biopharmaceutical innovations.
Novavax
NVAX
Mkt Cap1.36B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with YS Biopharma's focus on therapeutic solutions.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a large pharmaceutical company with a broad product portfolio that includes biopharmaceuticals, competing in various therapeutic areas with YS Biopharma.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of products that compete with YS Biopharma's biopharmaceutical solutions.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a global biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including those in areas where YS Biopharma operates.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a healthcare company that researches and develops pharmaceuticals, vaccines, and consumer healthcare products, competing with YS Biopharma in the biopharmaceutical field.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is known for its high-quality medicines, vaccines, biologic therapies, and animal health products, competing across several of YS Biopharma's key areas.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, directly competing with YS Biopharma in the development of innovative therapeutic solutions.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally in pharmaceuticals, covering a broad range of therapeutic areas and competing with YS Biopharma in the biopharmaceutical and vaccine sectors.

About

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Show more...
CEO
Dr. Yuan Liu Ph.D.
Employees
758
Country
KY
ISIN
KYG9845F1090

Listings

OTC Link
US
LSBCF
OTC Link
US
LSBWF
XNAS
US
LSB

0 Comments

Share your thoughts

FAQ

What is LakeShore Biopharma stock price today?▼
The current price of LSB is $0.63 USD — it has decreased by -20.68% in the past 24 hours. Watch LakeShore Biopharma stock price performance more closely on the chart.
What is LakeShore Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LakeShore Biopharma stocks are traded under the ticker LSB.
Is LakeShore Biopharma stock price growing?▼
LSB stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year LakeShore Biopharma has showed a -73.88% decrease.
What were LakeShore Biopharma earnings last quarter?▼
LSB earnings for the last quarter are -0.73 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is LakeShore Biopharma revenue for the last year?▼
LakeShore Biopharma revenue for the last year amounts to 79.17M USD.
What is LakeShore Biopharma net income for the last year?▼
LSB net income for the last year is -59.85M USD.
How many employees does LakeShore Biopharma have?▼
As of April 01, 2026, the company has 758 employees.
In which sector is LakeShore Biopharma located?▼
LakeShore Biopharma operates in the Health Care sector.
When did LakeShore Biopharma complete a stock split?▼
The last stock split for LakeShore Biopharma was on October 04, 2024 with a ratio of 1:10.
Where is LakeShore Biopharma headquartered?▼
LakeShore Biopharma is headquartered in Beijing, KY.